19 March 2012

09:00 - 11:00 
REGISTRATION
11:00 - 13:00 
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
DEVELOPED WITH THE SOCIETY FOR ENDOCRINOLOGY'S PITUITARY SPECIAL INTEREST GROUP AND THE ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS
QUEEN'S SUITE A
Chairs: R Fowkes (London) & H Chahal (London)
11:00
S1.1
11:30
S1.2
N-A Liu (Los Angeles, CA, USA)
12:00
S1.3
J Martinez-Barbera (London)
12:30
S1.4
11:00 - 13:00 
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
Stress caused by unfolded and misfolded proteins in the endoplasmic reticulum (so called "ER stress") intersects with metabolic disease at multiple levels
QUEEN'S SUITE B
Chairs: P Chapple (London) & E Harno (Manchester)
11:00 - 13:00 
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
DEVELOPED WITH THE SOCIETY FOR ENDOCRINOLOGY'S ANDROLOGY SPECIAL INTEREST GROUP AND THE KLINEFELTER'S SYNDROME ASSOCIATION
MAIN AUDITORIUM
Chairs: R Quinton (Newcastle) & A Theodoraki (London)
13:00 - 13:30 
LUNCH
HALL Q
13:30 - 15:30 
Applied Physiology Workshop:
NANOMEDICINE
QUEEN'S SUITE B
Chairs: M Gurnell (Cambridge) & R Fowkes (London)
13:30
AP1.1
14:10
AP1.2
G Lanza (St Louis, MO, USA)
14:50
AP1.3
13:30 - 15:30 
Symposium 4: ADVANCES IN THE MANAGEMENT OF DIFFERENTIATED THYROID CANCER
Thyroid cancer management is evolving to reflect novel developments in imaging, cytology, molecular biology and the outcome of trials evaluating low versus high dose radioiodine therapy
MAIN AUDITORIUM
Chairs: K Boelaert (Birmingham) & P Newey (Oxford)
15:30 - 16:00 
TEA & COFFEE
HALL Q
16:00 - 18:00 
Oral Communications 2: REPRODUCTION AND BONE
QUEEN'S SUITE B
Chairs: A McNeilly (Edinburgh) & E Vasilopoulou (Birmingham)
16:00 - 18:00 
Symposium 5: SPRINT OR MARATHON? MUSCLING IN ON THE OLYMPICS
Muscle is recognised as important endocrine organ and target for the treatment of metabolic syndrome. This symposium will explore the breadth of our new understanding of basic metabolism and investigative clinical data that is currently emerging.
QUEEN'S SUITE A
Chairs: G Lavery (Birmingham) & N Morton (Edinburgh)
16:00
S5.1
B Pedersen (Copenhagen, Denmark)
17:30
S5.4
16:00 - 18:00 
Clinical Management Workshop 1: THE LATE CONSEQUENCES OF CANCER THERAPY IN ADULTS
Two million people in the UK are living with or beyond cancer. Many are at risk of endocrinopathy
SUPPORTED BY CLINICAL ENDOCRINOLOGY, DEVELOPED WITH THE SOCIETY FOR ENDOCRINOLOGY'S LATE EFFECTS OF CANCER THERAPY SPECIAL INTEREST GROUP
MAIN AUDITORIUM
Chairs: M Druce (London) & A Kennedy (Birmingham)
16:00
CM1.1
D Greenfield (Sheffield)
16:30
CM1.2
17:30
CM1.4
18:00 - 18:10 
BREAK
18:10 - 19:10 
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
MAIN AUDITORIUM
Chairs: K Chapman (Edinburgh) & A Grossman (London)
19:10 - 21:00 
WELCOME RECEPTION
HALL Q
19:45 -  
YOUNG ENDOCRINOLOGISTS' SOCIAL EVENING
HALL D